A Comparison of the Extraction of Beta Blockers from Plasma Using Solid-Supported Liquid-Liquid Extraction and Traditional Liquid-Liquid Extraction

Importance of the Topic

The reliable extraction of beta-blockers from biological matrices is critical in clinical pharmacokinetics, therapeutic drug monitoring, and toxicology. Optimizing sample preparation improves analyte recovery, reduces processing time, and lowers solvent consumption, supporting higher throughput and cost-effective workflows in research and quality control laboratories.

Objectives and Study Overview

This application note compares solid-supported liquid-liquid extraction (SLE) using Thermo Scientific HyperSep cartridges with traditional liquid-liquid extraction (LLE) for isolating three beta-blockers (pindolol, metoprolol, propranolol) from human plasma. The study aims to evaluate recovery efficiency, reproducibility, solvent usage, and processing time for both techniques, demonstrating the potential of SLE to enhance laboratory operations.

Methodology and Instrumentation

• Sample matrix: Human plasma spiked to 0.05 mg/mL with each beta-blocker.
• SLE procedure: 200 μL plasma mixed with 200 μL 0.5 M NH₄OH, loaded onto a 200 mg/3 mL HyperSep cartridge, adsorbed for 5 minutes, eluted twice with 1 mL ethyl acetate, dried, and reconstituted in 200 μL water/methanol (95:5).
• LLE procedure: 500 μL plasma mixed with 500 μL 0.5 M NH₄OH, extracted twice with 1 mL ethyl acetate (15-minute mixing, 10-minute centrifugation), dried, and reconstituted in 500 μL water/methanol (95:5).
• Chromatographic separation: Thermo Scientific Accela 1250 HPLC system with Accucore C18 (2.6 μm, 50 × 2.1 mm) column; gradient 10–40% methanol + 0.1% formic acid over 2.5 minutes; flow 0.7 mL/min; 45 °C; UV detection at 220 nm; 2 μL injection.

Main Results and Discussion

• Recoveries: SLE achieved 79–88% average recoveries versus 26–60% for LLE, with comparable reproducibility (%RSD 9–13%).
• Throughput: Processing 96 samples required 30 minutes with SLE compared to 140 minutes with LLE, yielding a 110-minute time saving.
• Solvent and sample savings: SLE used 200 μL sample and modifier versus 500 μL each for LLE, while elution solvent volumes were equivalent (2 mL); overall solvent usage was similar but with lower handling volumes.
• Chromatography: All three analytes eluted in under three minutes with baseline resolution on the Accucore column, demonstrating efficient separation suitable for high-throughput assays.

Benefits and Practical Applications

• Enhanced recovery enables lower sample and reagent consumption, reducing costs and preservative requirements.
• Elimination of emulsion formation and simplified workflow facilitates automation on standard liquid-handling platforms.
• Significant reduction in hands-on and total processing time boosts sample throughput in clinical, forensic, and pharmaceutical laboratories.

Future Trends and Opportunities

• Integration of SLE with online automated systems and direct coupling to LC-MS for streamlined bioanalysis.
• Application of SLE to a broader range of moderately polar to nonpolar drugs and metabolites.
• Development of greener extraction solvents and miniaturized cartridge formats to further lower environmental impact.
• Advancements in sorbent chemistries to accommodate complex matrices and trace-level analytes.

Conclusion

This comparative study demonstrates that HyperSep SLE outperforms traditional LLE for extracting beta-blockers from plasma, delivering up to three-fold higher recoveries, five-fold faster processing, and reduced sample and reagent demands. The efficient, automation-compatible workflow supports high throughput and cost savings, making SLE a compelling choice for routine bioanalytical applications.